Skip to content

RECTAL VERSUS INTRAMUSCULAR DICLOFENAC SODIUM FOR PAIN RELIEF AFTER CAESAREAN SECTION: A SINGLE BLIND RANDOMISED CONTROL STUDY

RECTAL VERSUS INTRAMUSCULAR DICLOFENAC SODIUM FOR PAIN RELIEF AFTER CAESAREAN SECTION: A SINGLE BLIND RANDOMISED CONTROL STUDY

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202210622254726
Enrollment
242
Registered
2022-10-24
Start date
2022-10-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

diclofenac sodium for pain relief after caesarean using intramuscular r rectal route.
diclofenac sodium for pain relief after caesarean section following intramuscular or rectal route.

Sponsors

DR UGWU PAULINUS CHUKWUEMEKA
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Booked participants for elective or emergency lower segment caesarean delivery under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1. Participants booked for caesarean delivery under general anaesthesia. 2. Participants with medical condition known to be potentially exacerbated by non-steroidal anti-inflammatory drugs such as peptic ulcer disease. 3. Participants with previous history of adverse reaction or hypersensitivity to diclofenac or pentazocin. 4. Participants who require special post-operative pain control such as sickle cell disease patient. 5. Participant with known renal disease. 6. Participants with known liver disease.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will be the effectiveness of diclofenac sodium for pain relief after caesarean section using rectal or intramuscular route that will be assessed using Visual Analogue Scale (VAS) for pain assessment.

Secondary

MeasureTime frame
The secondary outcome measures are maternal satisfaction, adverse and side effects of the study drugs.

Countries

Nigeria

Contacts

Public ContactAKUNEZIRI UCHE

CONSULTANT OBSTETRICIAN AND GYNAECOLOGIST

ucheakuneziri@gmail.com+2348036302463

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026